Cancer of Unknown Primary

AI model traces cancers of unknown primary origin to their sources

By LabPulse.com staff writers

In results from a study published recently in Nature, OncoNPC was able to accurately predict the origin of about 80% of the tumors tested, including metastatic disease.

August 8, 2023

NGS is transforming diagnostics, but is it right for everyone?

By Joseph Constance

Sequencing shows if a gene contains variants or mutations linked to an illness or a disorder. NGS offers a way to complement, or replace, many conventional laboratory tests, and it is finding applications in microbiome analysis, metagenomics, transcriptome profiling, infectious disease and oncology diagnosis, pathogen discovery, and public health surveillance, among other areas.

August 31, 2021

Week in Review: Coronavirus stool samples under scrutiny | Testing company accused of fraud | Genetic risk scoring in heart disease

By Emily Hayes

Dear LabPulse Member,

June 11, 2020

ACP advises biennial -- not annual -- stool tests for colon cancer

By Emily Hayes

After reviewing guidelines from several bodies for people with average risk for colorectal cancer (CRC) -- for example, they do not have a family history -- the ACP advised that screening should be done between the ages of 50 and 75. Four different options are recommended:

November 4, 2019